• Explore /
  • Poster
  • / Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive (PS) recurrent ovarian cancer (rOC)? A network meta-analysis (NMA).

Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive (PS) recurrent ovarian cancer (rOC)? A network meta-analysis (NMA).

Abstract Poster

Authors

null

Michele Bartoletti

Department of Medicine (DAME), University of Udine; Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Udine, Italy

Michele Bartoletti , Giacomo Pelizzari , Lorenzo Gerratana , Silvio Ken Garattini , Debora Basile , Camilla Lisanti , Lucia Bortot , Carla Corvaja , Mattia Garutti , Simona Scalone , Milena Nicoloso , Silvia Bolzonello , Elena Torrisi , Lucia Da Ros , Paola Di Nardo , Davide Lombardi , Giorgio Giorda , Gustavo Baldassarre , Roberto Sorio , Fabio Puglisi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5564)

DOI

10.1200/JCO.2019.37.15_suppl.5564

Abstract #

5564

Poster Bd #

387

Abstract Disclosures

Similar Posters

First Author: Debra L. Richardson

First Author: JUNG-YUN LEE

First Author: Mansoor Raza Mirza

First Author: Mansoor Raza Mirza